Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

中和 抗体 病毒学 贪婪 表位 生物 重链 2019年冠状病毒病(COVID-19) 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 恢复期血浆 中和抗体 病毒 免疫学 医学 传染病(医学专业) 疾病 病理
作者
Jianliang Xu,Kai Xu,Seolkyoung Jung,A. Conte,Jenna Ariel Lieberman,Frauke Muecksch,Julio C. C. Lorenzi,Solji Park,Fabian Schmidt,Zijun Wang,Yaoxing Huang,Yang Luo,Manoj S. Nair,Pengfei Wang,Jonathan E. Schulz,Lino Tessarollo,Tatsiana Bylund,Gwo‐Yu Chuang,Adam S. Olia,Tyler Stephens,I‐Ting Teng,Yaroslav Tsybovsky,Tongqing Zhou,Vincent J. Munster,David D. Ho,Théodora Hatziioannou,Paul D. Bieniasz,Michel C. Nussenzweig,Peter D. Kwong,Rafael Casellas
出处
期刊:Nature [Nature Portfolio]
卷期号:595 (7866): 278-282 被引量:174
标识
DOI:10.1038/s41586-021-03676-z
摘要

Abstract Since the start of the COVID-19 pandemic, SARS-CoV-2 has caused millions of deaths worldwide. Although a number of vaccines have been deployed, the continual evolution of the receptor-binding domain (RBD) of the virus has challenged their efficacy. In particular, the emerging variants B.1.1.7, B.1.351 and P.1 (first detected in the UK, South Africa and Brazil, respectively) have compromised the efficacy of sera from patients who have recovered from COVID-19 and immunotherapies that have received emergency use authorization 1–3 . One potential alternative to avert viral escape is the use of camelid VHHs (variable heavy chain domains of heavy chain antibody (also known as nanobodies)), which can recognize epitopes that are often inaccessible to conventional antibodies 4 . Here, we isolate anti-RBD nanobodies from llamas and from mice that we engineered to produce VHHs cloned from alpacas, dromedaries and Bactrian camels. We identified two groups of highly neutralizing nanobodies. Group 1 circumvents antigenic drift by recognizing an RBD region that is highly conserved in coronaviruses but rarely targeted by human antibodies. Group 2 is almost exclusively focused to the RBD–ACE2 interface and does not neutralize SARS-CoV-2 variants that carry E484K or N501Y substitutions. However, nanobodies in group 2 retain full neutralization activity against these variants when expressed as homotrimers, and—to our knowledge—rival the most potent antibodies against SARS-CoV-2 that have been produced to date. These findings suggest that multivalent nanobodies overcome SARS-CoV-2 mutations through two separate mechanisms: enhanced avidity for the ACE2-binding domain and recognition of conserved epitopes that are largely inaccessible to human antibodies. Therefore, although new SARS-CoV-2 mutants will continue to emerge, nanobodies represent promising tools to prevent COVID-19 mortality when vaccines are compromised.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
思源应助xnzll采纳,获得10
刚刚
1秒前
歪歪发布了新的文献求助10
1秒前
So发布了新的文献求助10
1秒前
活泼芷文发布了新的文献求助10
2秒前
略略略应助团装采纳,获得10
2秒前
予安发布了新的文献求助10
2秒前
jiashan完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
甜芋发布了新的文献求助10
3秒前
123发布了新的文献求助10
3秒前
JamesPei应助ncjdoi采纳,获得10
3秒前
4秒前
聪明水之发布了新的文献求助10
4秒前
豆子应助稳重向南采纳,获得20
4秒前
研友_VZG7GZ应助望北楼主采纳,获得10
4秒前
Chambray发布了新的文献求助10
4秒前
6秒前
6秒前
甜美坤完成签到 ,获得积分10
6秒前
So完成签到,获得积分10
7秒前
8秒前
8秒前
范海辛完成签到,获得积分10
8秒前
小小完成签到,获得积分10
8秒前
难过千易发布了新的文献求助10
8秒前
共享精神应助潇洒的尔风采纳,获得10
8秒前
Rondab应助WPP采纳,获得10
9秒前
9秒前
10秒前
11秒前
我是老大应助包子的开心采纳,获得10
11秒前
光亮笑柳发布了新的文献求助10
12秒前
12秒前
12秒前
12秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974797
求助须知:如何正确求助?哪些是违规求助? 3519250
关于积分的说明 11197623
捐赠科研通 3255405
什么是DOI,文献DOI怎么找? 1797769
邀请新用户注册赠送积分活动 877156
科研通“疑难数据库(出版商)”最低求助积分说明 806202